Genomics & Sequencing AI
DNAnexus
by DNAnexus, Inc.
Secure cloud platform for genomic data management, analysis, and collaboration at scale
Category
Genomics & Sequencing AI
Founded
2009
Headquarters
San Francisco, CA, USA
Overview
DNAnexus is a cloud-based genomic data management and analysis platform purpose-built for the security, compliance, and scale requirements of clinical genomics, population health, and pharmaceutical research. The platform provides secure data storage with fine-grained access controls, a scalable execution environment for bioinformatics workflows (supporting WDL, CWL, and Nextflow), and a marketplace of validated genomic applications from partners including Illumina, Sentieon, and others. Clinical labs, population genomics programs, and pharmaceutical R&D organizations use DNAnexus to manage petabyte-scale genomic datasets, run standardized variant calling and analysis pipelines, and collaborate across institutions without transferring protected health information. The platform underpins major population genomics initiatives including the UK Biobank Research Access Environment, supporting thousands of researchers accessing half a million whole genome sequences. DNAnexus differentiates through its clinical-grade security posture — the platform maintains HIPAA, GDPR, ISO 27001, and SOC 2 certifications and operates across multiple cloud providers (AWS, Google Cloud, Azure). Unlike general-purpose bioinformatics clouds, DNAnexus provides governance tooling, audit trails, and data access agreements that meet the requirements of regulated clinical and pharmaceutical environments.
Key Features
Clinical-Grade Accuracy
Validated against benchmark datasets achieving 99.9%+ concordance for clinical applications.
Comprehensive Variant Calling
Detect SNVs, indels, structural variants, and copy number variations from a single pipeline.
Ultra-Fast Secondary Analysis
Process whole genome sequencing data in under 30 minutes with hardware-accelerated algorithms.
Real-Time QC Dashboard
Monitor sequencing run quality metrics in real-time with automated alerts for quality deviations.
Cloud & On-Premises Deployment
Flexible deployment options satisfying diverse data governance and regulatory requirements.
Pros & Cons
Pros
- +Integration with major sequencing platforms (Illumina, PacBio, Oxford Nanopore) ensures broad compatibility
- +Population-scale analysis capabilities handle thousands of genomes in parallel
- +Comprehensive variant calling supports SNVs, indels, SVs, and CNVs from a single pipeline
- +Hardware-accelerated algorithms reduce computational costs by 10x compared to software-only pipelines
- +Ultra-fast secondary analysis processes whole genome sequencing data in under 30 minutes
- +Cloud and on-premises deployment options satisfy diverse data governance requirements
Cons
- −Large-scale genomic data storage and transfer creates significant infrastructure costs
- −Rapid algorithm evolution means today's state-of-the-art may be outdated within 1-2 years
- −Clinical validation requirements differ across regulatory jurisdictions adding complexity
- −Hardware-specific optimizations may create vendor lock-in to particular sequencing platforms
- −Variant interpretation for novel or rare variants remains challenging despite AI assistance
Use Cases
Whole Genome Analysis
Ultra-fast secondary analysis of whole genome sequencing data with comprehensive variant calling in under 30 minutes.
Clinical Variant Interpretation
AI-powered classification of genetic variants with clinical-grade accuracy for diagnostic applications.
Population Genomics
Scalable analysis of thousands of genomes in parallel for population-scale genetic studies.